Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review
Baxter GD, Liu L, Petrich S, Gisselman AS, Chapple C, Anders JJ, Tumilty S
BMC cancer · 78 citas
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Organización sin fines de lucro
- Breast Cancer Foundation New Zealand
- Organización sin fines de lucro
- New Zealand Breast Cancer Foundation
Según 2 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2017-12-01 · BMC Cancer · vol. 17 · número 1 · pág. 833
- Editorial
- BioMed Central
- Citado
- 150 citas · más que el 75% de estudios similares · 0.9× el promedio de su campo
- Referencias
- 60 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Lymphatic System and Diseases · Diagnosis and Treatment of Venous Diseases · Body Contouring and Surgery
- Palabras clave
- Medicine, Lymphedema, Surgical oncology, Breast cancer, Low level laser therapy, Cancer therapy, Laser therapy, Oncology, Cancer, Radiation therapy, Internal medicine, Laser
- MeSH
- humans, female, randomized controlled trials as topic, low-level light therapy, breast cancer lymphedema
7 autores
- David G. Baxter🇳🇿 · autor de correspondenciaUniversity of Otago
- Lizhou Liu🇳🇿University of Otago
- Simone Petrich🇳🇿Southern District Health Board
- Angela Spontelli Gisselman🇳🇿University of Otago
- Cathy Chapple🇳🇿University of Otago
- Juanita J. Anders🇺🇸Uniformed Services University of the Health Sciences
- Steve Tumilty🇳🇿University of Otago
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Breast cancer related lymphedema (BCRL) is a prevalent complication secondary to cancer treatments which significantly impacts the physical and psychological health of breast cancer survivors. Previous research shows increasing use of low level laser therapy (LLLT), now commonly referred to as photobiomodulation (PBM) therapy, for BCRL. This systematic review evaluated the effectiveness of LLLT (PBM) in the management of BCRL.
Methods
Clinical trials were searched in PubMed, AMED, Web of Science, and China National Knowledge Infrastructure up to November 2016. Two reviewers independently assessed the methodological quality and adequacy of LLLT (PBM) in these clinical trials. Primary outcome measures were limb circumference/volume, and secondary outcomes included pain intensity and range of motion. Because data were clinically heterogeneous, best evidence synthesis was performed.
Results
Eleven clinical trials were identified, of which seven randomized controlled trials (RCTs) were chosen for analysis. Overall, the methodological quality of included RCTs was high, whereas the reporting of treatment parameters was poor. Results indicated that there is strong evidence (three high quality trials) showing LLLT (PBM) was more effective than sham treatment for limb circumference/volume reduction at a short-term follow-up. There is moderate evidence (one high quality trial) indicating that LLLT (PBM) was more effective than sham laser for short-term pain relief, and limited evidence (one low quality trial) that LLLT (PBM) was more effective than no treatment for decreasing limb swelling at short-term follow-up.
Conclusions
Based upon the current systematic review, LLLT (PBM) may be considered an effective treatment approach for women with BCRL. Due to the limited numbers of published trials available, there is a clear need for well-designed high-quality trials in this area. The optimal treatment parameters for clinical application have yet to be elucidated.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.